Skip to content

Management Standard of Bone Marrow Infusion in Acute and Critical Patients

Application Value of Precision Management Standard of Bone Marrow Infusion in Acute and Critical Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04951596
Enrollment
100
Registered
2021-07-07
Start date
2020-07-01
Completion date
2022-12-31
Last updated
2021-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Patients

Keywords

Acute and critically ill patients, Intraosseous infusion, Management standards

Brief summary

As the spike in the number and severity of patients with critical patients, then quickly effective transfusion treatment demand becomes more and more serious, and the pattern of infusion pathways have traditionally used already can not adapt to this change, therefore, an urgent need to establish a set of is in line with international standards and accord with the situation of our country is simple, effective and scientific accuracy of IO management solution. In order to ensure the safety of the treatment of acute and critical patients, and in the province and even domestic experts recognized and promoted the application.

Detailed description

1. Investigate the current situation of infusion treatment for critical and critical patients in two hospitals in the province, the cognition of medical staff in critical and critical units on IO, IO training and assessment, and continuous quality improvement, etc. A comprehensive understanding of the needs of medical staff in the acute critical care unit for the refined IO management standard, including the analysis of the application of the standard in some hospitals. 2. Clarify and refine the contents of relevant indexes of IO management standards to form a standardized, scientific, unified and simple way to quickly judge difficult vessels. Defining the appropriate infusion access, infusion tool, puncture site, infusion speed, infusion effect, patient outcome, complications, indications, contraindication, infusion risk management, relevant personnel training and assessment, and continuous quality improvement as indexes. 3. On the basis of the standards of existing guidelines, a reasonable observation time range and the number of puncture times consistent with the first infusion puncture were established.

Interventions

OTHERInvestigate the current situation

Investigate the current situation of infusion treatment for acute and critical patients in 2 hospitals in the province

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 1.Emergency medical staffMore than two years of critical work experience 2.Volunteer to participate in research

Exclusion criteria

* Patients who have neurological disease

Design outcomes

Primary

MeasureTime frameDescription
complications in patients with intraosseous infusionone and a half yearsThe number of complications occurred in the bone marrow cavity was calculated
time of infufusion access establishment for patientsone and a half yearsThe time of catheterization for each bone marrow cavity puncture was recorded
Success rate of infusion access establishmentone and a half yearsThe success rate of establishing the infusion access was calculated

Countries

China

Contacts

Primary Contactminfei yang
2200056@zju.edu.cn+86 13757118252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026